Skip to content
‹ Back to IndustriesSciences

New Study: Probiotic DE111® Shown to Promote a Healthy Microbiome for Immune Support in Daycare-Attending Children

KENNESAW, GA (December 2, 2020) – Deerland Probiotics and Enzymes has announced the publication of a clinical study showing that the administration of the probiotic Bacillus subtilis DE111® can modify the composition of the microbiome in preschool-aged children. The study, “Daily intake of probiotic strain Bacillus subtilis DE111 supports a healthy microbiome in children attending day-care” published in Beneficial Microbes,…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · ChildrenCovid-19DaycareDeerland Probiotics & Enzymes
Share
New Study: Probiotic DE111® Shown to Promote a Healthy Microbiome for Immune Support in Daycare-Attending Children

Key takeaways

01

KENNESAW, GA (December 2, 2020) – Deerland Probiotics and Enzymes has announced the publication of a clinical study showing that the administration of the probiotic Bacillus subtilis DE111® can modify the composition of the microbiome in preschool-aged children.

02

The study, “Daily intake of probiotic strain Bacillus subtilis DE111 supports a healthy microbiome in children attending day-care” published in Beneficial Microbes,…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

KENNESAW, GA (December 2, 2020) – Deerland Probiotics and Enzymes has announced the publication of a clinical study showing that the administration of the probiotic Bacillus subtilis DE111® can modify the composition of the microbiome in preschool-aged children.

The study, “Daily intake of probiotic strain Bacillus subtilis DE111 supports a healthy microbiome in children attending day-care” published in Beneficial Microbes, is an IRB-approved, randomized, double-blind, placebo-controlled four-week trial involving 91 children aged 2 to 6. Results of the study showed that daily consumption of the probiotic strain Bacillus subtilis DE111 positively modulated the gut microbiome profile without changing the overall microbiome equilibrium.

After 8 weeks of daily probiotic consumption, the researchers observed an increase in alpha-diversity at the phylum level, suggesting an expanded functional diversity of the microbiome compared to that of the children in the placebo group. Specifically, there were 9 differentially abundant taxa at the genus level found in the probiotic group, six (of the phylum bacteroidetes) grew in abundance while three (of the phylum firmicutes) were reduced. The six taxa of bacteroidetes that flourished are involved in immune regulation and reduction of inflammation. This modulation of the firmicutes/bacteroidetes ratio of the microbiome in children taking B. subtilis DE111 is a positive indication for healthy gut function.

Overall, according to the researchers, these results suggest B. subtilis DE111 supports the maintenance of a healthy gut through subtle modulations of the microbiome with significant benefits in preschool aged children.

“On the dawn of a new highly modified school year where health takes center stage, this study is highly encouraging to formulate natural, safe products for young children to promote immunity and overall well-being so they can concentrate on learning,” said John Deaton, vice president of science and technology at Deerland. “Focusing on supporting a healthy microbiome will result in more robust and effective immunity as children get older.”

Deerland Probiotics & Enzymes, based in Kennesaw, Ga., specializes in developing science-backed solutions that benefit microbiome health, using probiotic, prebiotic and enzyme technology. The company offers a line of unique, clinically validated branded products, including DE111®, PreforPro®, ProHydrolase®, Solarplast®, Glutalytic® and Bifolac® probiotic strains. Deerland collaborates with customers to develop innovative and often proprietary solutions in the dietary supplement, food and beverage, sports nutrition, and companion animal markets. In addition to branded ingredients and customized formulations, Deerland offers full turnkey products for private label through its YourBrand® portfolio. The company’s manufacturing services include bulk blends, capsules, stick packs and tablets, as well as bottling and labeling. To contact Deerland Probiotics & Enzymes, call 800.697.8179 or visit www.deerland.com.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Peptide drug runs can stall on late raw materials, Frost & Sullivan and Medtide find

Peptide drug runs can stall on late raw materials, Frost & Sullivan and Medtide find

Frost & Sullivan and Medtide's 2026 white paper on peptide and oligonucleotide drugs ties contract manufacturer selection to program stage. Its sharpest point is that a late resin, amino acid or nucleotide building block can stall a campaign even with plant capacity free. Supplier depth belongs in CDMO qualification.

  • 01Open capacity at a contract manufacturer means little if a nonstandard amino acid or a modified nucleotide building block arrives late, so the supplier list deserves the same scrutiny as the capacity reservation.
  • 02What makes a good CDMO changes as a program matures: speed of problem solving decides early clinical timelines, while proven scale-up, raw-material access, reserved capacity and site-to-site transfer decide launch readiness.
  • 03A useful question for any prospective partner is which critical inputs for a given molecule already have a second qualified supplier, because switching sources later can trigger extra quality testing.

Nov 22, 2026

Merck's $550 million lab was built for robots whose specs weren't final

Merck's $550 million lab was built for robots whose specs weren't final

Merck's $550 million ADVANCE lab in West Point, Pennsylvania, which opened in October 2026, reserved floor space for robots before some of them had final dimensions. Containment sits inside robotic work cells, space and utilities were sized for the largest expected machines, and validation waited until construction ended. Other lab capital projects can reuse that order of work.

  • 01When robotic platforms carry their own enclosures, walls are needed mainly where the science or access control demands them, and the open floor plan is designed to make future equipment swaps easier without automatically forcing new room build-outs.
  • 02Merck planned for the largest expected robot sizes and highest utility needs, using lessons from its 2023 Spring House lab, according to Lab Design News. Teams without a previous project to learn from could find those limits harder to set.

Nov 21, 2026

Keller’s case for carbs as key fuel for post-workout muscle repair

Keller’s case for carbs as key fuel for post-workout muscle repair

In a NuLiv Science segment, nutrition scientist and dietitian Dr. Rosa Keller argues that carbohydrate (glucose) is a key fuel for mitochondrial ATP after resistance training and that clients often under-eat carbs. The article cites reviews emphasizing carbohydrate for glycogen restoration (including John Ivy’s 1.2 g/kg/hour post-exercise target), describes protein as a co-ingested partner in recovery, and notes ketogenic-diet findings that may benefit aging mitochondria.

  • 01John Ivy's post-exercise carbohydrate target is about 1.2 grams per kilogram of body weight per hour, taken early and often, to maximize glycogen resynthesis.
  • 02Nature Metabolism describes carbohydrate as the primary fuel for ATP in most Olympic events, and Keller argues that post-exercise repair depends on mitochondria having fuel to generate ATP.
  • 03Ketogenic diets improve muscle mitochondrial mass and function with age or disease but not in athletes, Pathak and Baar concluded, so the carbohydrate rule depends on who is training.

Nov 20, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512